Medtronic PE Ratio 2010-2025 | MDT
Current and historical p/e ratio for Medtronic (MDT) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Medtronic PE ratio as of August 18, 2025 is 16.91.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Medtronic PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-08-18 | 92.81 | 25.64 | |
| 2025-04-30 | 84.06 | $3.62 | 23.22 |
| 2025-01-31 | 89.36 | $3.29 | 27.16 |
| 2024-10-31 | 87.07 | $3.27 | 26.63 |
| 2024-07-31 | 77.74 | $2.96 | 26.26 |
| 2024-04-30 | 76.98 | $2.75 | 27.99 |
| 2024-01-31 | 83.29 | $3.14 | 26.53 |
| 2023-10-31 | 66.58 | $3.07 | 21.69 |
| 2023-07-31 | 82.11 | $2.71 | 30.30 |
| 2023-04-30 | 84.43 | $2.82 | 29.94 |
| 2023-01-31 | 77.03 | $3.04 | 25.34 |
| 2022-10-31 | 79.68 | $3.22 | 24.74 |
| 2022-07-31 | 83.73 | $3.87 | 21.64 |
| 2022-04-30 | 93.73 | $3.73 | 25.13 |
| 2022-01-31 | 92.40 | $3.63 | 25.45 |
| 2021-10-31 | 106.33 | $3.47 | 30.64 |
| 2021-07-31 | 115.92 | $2.86 | 40.53 |
| 2021-04-30 | 115.00 | $2.66 | 43.23 |
| 2021-01-31 | 97.30 | $2.14 | 45.47 |
| 2020-10-31 | 87.46 | $2.62 | 33.38 |
| 2020-07-31 | 83.43 | $3.27 | 25.51 |
| 2020-04-30 | 83.87 | $3.55 | 23.63 |
| 2020-01-31 | 98.56 | $3.94 | 25.01 |
| 2019-10-31 | 92.53 | $3.46 | 26.74 |
| 2019-07-31 | 86.18 | $3.27 | 26.36 |
| 2019-04-30 | 74.67 | $3.42 | 21.83 |
| 2019-01-31 | 73.91 | $3.62 | 20.42 |
| 2018-10-31 | 74.69 | $1.65 | 45.26 |
| 2018-07-31 | 74.65 | $2.31 | 32.32 |
| 2018-04-30 | 65.91 | $2.26 | 29.16 |
| 2018-01-31 | 70.24 | $2.03 | 34.60 |
| 2017-10-31 | 65.48 | $3.65 | 17.94 |
| 2017-07-31 | 67.88 | $2.97 | 22.86 |
| 2017-04-30 | 66.82 | $2.89 | 23.12 |
| 2017-01-31 | 60.81 | $2.83 | 21.49 |
| 2016-10-31 | 65.22 | $3.01 | 21.67 |
| 2016-07-31 | 69.34 | $2.57 | 26.98 |
| 2016-04-30 | 62.32 | $2.48 | 25.13 |
| 2016-01-31 | 59.47 | $1.70 | 34.98 |
| 2015-10-31 | 57.62 | $1.91 | 30.17 |
| 2015-07-31 | 60.77 | $2.38 | 25.53 |
| 2015-04-30 | 57.43 | $2.68 | 21.43 |
| 2015-01-31 | 54.86 | $3.12 | 17.58 |
| 2014-10-31 | 52.15 | $2.89 | 18.05 |
| 2014-07-31 | 47.01 | $2.95 | 15.93 |
| 2014-04-30 | 44.57 | $3.01 | 14.81 |
| 2014-01-31 | 42.66 | $3.52 | 12.12 |
| 2013-10-31 | 43.08 | $3.74 | 11.52 |
| 2013-07-31 | 41.25 | $3.48 | 11.85 |
| 2013-04-30 | 34.67 | $3.38 | 10.26 |
| 2013-01-31 | 34.42 | $3.37 | 10.21 |
| 2012-10-31 | 30.52 | $3.28 | 9.31 |
| 2012-07-31 | 28.76 | $3.47 | 8.29 |
| 2012-04-30 | 27.69 | $3.41 | 8.12 |
| 2012-01-31 | 27.79 | $3.19 | 8.71 |
| 2011-10-31 | 24.87 | $3.17 | 7.85 |
| 2011-07-31 | 25.61 | $2.87 | 8.92 |
| 2011-04-30 | 29.47 | $2.86 | 10.30 |
| 2011-01-31 | 26.90 | $3.00 | 8.97 |
| 2010-10-31 | 24.58 | $2.89 | 8.50 |
| 2010-07-31 | 25.62 | $3.15 | 8.13 |
| 2010-04-30 | 30.09 | $2.79 | 10.78 |
| 2010-01-31 | 29.40 | $2.15 | 13.68 |
| 2009-10-31 | 24.36 | $2.05 | 11.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $119.233B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.305B | 26.89 |
| Boston Scientific (BSX) | United States | $152.872B | 36.46 |
| Stryker (SYK) | United States | $146.007B | 29.72 |
| EssilorLuxottica (ESLOY) | France | $145.127B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.282B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.313B | 24.74 |
| ResMed (RMD) | United States | $41.712B | 29.83 |
| Agilent Technologies (A) | United States | $33.861B | 22.07 |
| GE HealthCare Technologies (GEHC) | United States | $33.512B | 15.75 |
| Terumo (TRUMY) | Japan | $27.642B | 32.75 |
| Koninklijke Philips (PHG) | Netherlands | $26.451B | 17.50 |
| Insulet (PODD) | United States | $22.615B | 75.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.354B | 12.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.855B | 0.00 |
| Baxter (BAX) | United States | $12.419B | 9.60 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.731B | 28.40 |
| Lantheus Holdings (LNTH) | United States | $3.684B | 9.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.430B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.198B | 14.19 |
| Perrigo (PRGO) | Ireland | $3.123B | 7.80 |
| ICU Medical (ICUI) | United States | $2.986B | 20.33 |
| Haemonetics (HAE) | United States | $2.589B | 11.56 |
| LeMaitre Vascular (LMAT) | United States | $2.171B | 46.56 |
| Curaleaf Holdings (CURLF) | Canada | $1.782B | 0.00 |
| AtriCure (ATRC) | United States | $1.762B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.761B | 11.08 |
| Green Thumb Industries (GTBIF) | United States | $1.601B | 68.73 |
| AdaptHealth (AHCO) | United States | $1.283B | 18.24 |
| Phibro Animal Health (PAHC) | United States | $1.243B | 15.89 |
| Acuren (TIC) | United States | $1.190B | 0.00 |
| Neogen (NEOG) | United States | $1.179B | 18.72 |
| BioLife Solutions (BLFS) | United States | $1.166B | 2434.00 |
| Tilray Brands (TLRY) | Canada | $1.134B | 0.00 |
| Valneva SE (VALN) | France | $0.981B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 8.39 |
| Kestra Medical Technologies (KMTS) | United States | $0.824B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.665B | 0.00 |
| Surmodics (SRDX) | United States | $0.536B | 0.00 |
| ZimVie (ZIMV) | United States | $0.532B | 20.49 |
| SNDL (SNDL) | Canada | $0.531B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.482B | 0.00 |
| CeriBell (CBLL) | United States | $0.451B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.451B | 15.53 |
| Owens & Minor (OMI) | United States | $0.439B | 3.89 |
| Verano Holdings (VRNOF) | United States | $0.438B | 0.00 |
| Evolus (EOLS) | United States | $0.435B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.364B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.330B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.312B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.287B | 0.00 |
| Omeros (OMER) | United States | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 20.26 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.254B | 0.00 |
| Brainsway (BWAY) | Israel | $0.245B | 49.92 |
| Cerus (CERS) | United States | $0.238B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.234B | 0.00 |
| High Tide (HITI) | Canada | $0.216B | 0.00 |
| Quanterix (QTRX) | United States | $0.212B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.202B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.83 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.156B | 0.00 |
| Biote (BTMD) | United States | $0.144B | 4.79 |
| Jushi Holdings (JUSHF) | United States | $0.116B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Jin Medical (ZJYL) | China | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.094B | 12.08 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Safety Shot (SHOT) | United States | $0.078B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.073B | 0.00 |
| Agape ATP (ATPC) | $0.063B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.12 |
| Veru (VERU) | United States | $0.053B | 0.00 |
| Zynex (ZYXI) | United States | $0.046B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 35.42 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.05 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.029B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |